Current reports
8-K
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
9 May 24
8-K
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
1 Apr 24
8-K
Regulation FD Disclosure
4 Mar 24
8-K
NewAmsterdam Pharma Reports Full Year 2023 Financial Results and Provides Corporate Update
28 Feb 24
8-K
NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
15 Feb 24
8-K
Regulation FD Disclosure
22 Jan 24
8-K
NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors
8 Jan 24
8-K
NewAmsterdam Pharma Announces 2024 Strategic Priorities
4 Jan 24
6-K
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter 2023 Financial Highlights
13 Nov 23
6-K
NewAmsterdam Pharma Announces Appointment of Ian Somaiya as Chief Financial Officer
23 Oct 23
Registration and prospectus
424B3
Prospectus supplement
19 Apr 24
POS AM
Prospectus update (post-effective amendment)
12 Apr 24
424B3
Prospectus supplement
12 Mar 24
POS AM
Prospectus update (post-effective amendment)
28 Feb 24
424B5
Prospectus supplement for primary offering
15 Feb 24
424B5
Prospectus supplement for primary offering
13 Feb 24
424B3
Prospectus supplement
19 Dec 23
F-3
Shelf registration (foreign)
7 Dec 23
424B3
Prospectus supplement
13 Nov 23
424B3
Prospectus supplement
21 Sep 23
Other
EFFECT
Notice of effectiveness
18 Apr 24
EFFECT
Notice of effectiveness
11 Mar 24
EFFECT
Notice of effectiveness
20 Dec 23
EFFECT
Notice of effectiveness
14 Aug 23
EFFECT
Notice of effectiveness
25 Apr 23
EFFECT
Notice of effectiveness
31 Jan 23
CORRESP
Correspondence with SEC
26 Jan 23
CORRESP
Correspondence with SEC
17 Jan 23
UPLOAD
Letter from SEC
5 Jan 23
CERT
Certification of approval for exchange listing
22 Nov 22
Ownership
3
WILLIAM A JONES JR
3 May 24
4
Juliette Berangere Audet
2 Apr 24
4
James N Topper
28 Mar 24
4
Johannes Jacob Pieter Kastelein
27 Mar 24
144
Notice of proposed sale of securities
26 Mar 24
SC 13D/A
BCLS II Investco, LP
1 Mar 24
4
LOUIS G LANGE
21 Feb 24
SC 13D/A
Frazier Life Sciences X, L.P.
21 Feb 24
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Feb 24
SC 13G/A
VIKING GLOBAL INVESTORS LP
14 Feb 24